Compound Detail
CHEMBL465
DRONABINOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL465 |
| Name | DRONABINOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | CYQFCXCEBYINGO-IAGOWNOFSA-N |
| Therapeutic | ✓ Yes |
32
Targets
122
Activities
3
Assay Types
10
PK Parameters
20
Publications
22
Known Names
20
Indications
1
Mechanisms
Molecular Properties
314.5
MW (Da)
5.74
ALogP
2
HBA
1
HBD
29.5
PSA (Ų)
0.57
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cannabinoid CB1 receptor agonist | AGONIST | Cannabinoid receptor 1 | ✓ | ✓ |
Indications
Anorexia Nausea Nausea Nausea Neoplasms Vomiting Anorexia Nervosa Osteoarthritis, Knee Alcohol Drinking Amyotrophic Lateral Sclerosis Anemia, Sickle Cell Arthritis, Psoriatic Arthritis, Rheumatoid Child Development Disorders, Pervasive Chronic Pain Dementia HIV Infections Irritable Bowel Syndrome Marijuana Abuse Migraine with Aura
ATC Classification
A04AD10
dronabinol
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: ANTIEMETICS AND ANTINAUSEANTS
Activity Summary
Ki 71 meas. best 8.54
EC50 27 meas. best 8.85
IC50 24 meas. best 8.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cannabinoid receptor 2 CHEMBL253 | EC50 | 8.85 | 7.998 | 1.4 | 5 |
| Cannabinoid receptor 1 CHEMBL218 | IC50 | 8.55 | 8.55 | 2.8 | 1 |
| Cannabinoid receptor 1 CHEMBL218 | Ki | 8.54 | 7.6576 | 2.9 | 21 |
| Cannabinoid receptor 2 CHEMBL253 | Ki | 8.48 | 7.4564 | 3.3 | 25 |
| Mus musculus CHEMBL375 | IC50 | 8.4 | 8.4 | 4.0 | 2 |
| Cannabinoid receptor 1 CHEMBL3571 | IC50 | 8.24 | 8.24 | 5.8 | 1 |
| Cannabinoid receptor CHEMBL2111385 | IC50 | 8.24 | 7.45 | 5.8 | 2 |
| Cannabinoid receptor 1 CHEMBL218 | EC50 | 8.17 | 7.398 | 6.7 | 5 |
| Cannabinoid receptor 2 CHEMBL5373 | EC50 | 8.14 | 8.14 | 7.3 | 1 |
| Cannabinoid receptor 2 CHEMBL5373 | Ki | 8.04 | 7.5625 | 9.2 | 4 |
| Cannabinoid receptor 2 CHEMBL253 | IC50 | 8.02 | 8.02 | 9.5 | 1 |
| D(3) dopamine receptor CHEMBL234 | EC50 | 7.99 | 7.99 | 10.2 | 1 |
| Cannabinoid receptor 1 CHEMBL3571 | EC50 | 7.96 | 7.33 | 11.0 | 2 |
| Cannabinoid receptor 1 CHEMBL3037 | Ki | 7.82 | 7.5367 | 15.3 | 3 |
| Unchecked CHEMBL612545 | Ki | 7.7 | 6.61 | 20.0 | 3 |
| Cannabinoid receptor 1 CHEMBL3571 | Ki | 7.44 | 7.3473 | 36.0 | 11 |
| G-protein coupled receptor 183 CHEMBL3259470 | EC50 | 7.42 | 7.42 | 38.0 | 1 |
| Cannabinoid receptor CHEMBL2096981 | Ki | 7.39 | 7.39 | 41.0 | 1 |
| Cannabinoid receptor CHEMBL2111385 | Ki | 7.34 | 7.215 | 46.0 | 2 |
| Cannabinoid receptor 1 CHEMBL3037 | EC50 | 7.11 | 7.11 | 77.0 | 1 |
| Transient receptor potential cation channel subfamily M member 8 CHEMBL1075319 | IC50 | 6.8 | 6.8 | 160.0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 CHEMBL5160 | EC50 | 6.64 | 6.64 | 230.0 | 1 |
| Autotaxin CHEMBL3691 | EC50 | 6.34 | 6.34 | 460.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 6.14 | 6.12 | 720.0 | 2 |
| N-arachidonyl glycine receptor CHEMBL2384898 | EC50 | 6.02 | 5.5425 | 960.0 | 4 |
| Glycine receptor subunit alpha-1 CHEMBL5845 | EC50 | 5.89 | 5.89 | 1300.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Hemozoin CHEMBL613898 | IC50 | 4.95 | 4.95 | 11300.0 | 1 |
| Lysophosphatidylserine lipase ABHD12 CHEMBL5516 | IC50 | 4.94 | 4.94 | 11600.0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 CHEMBL3401 | EC50 | 4.9 | 4.7667 | 12600.0 | 3 |
| G-protein coupled receptor 55 CHEMBL1075322 | EC50 | 4.85 | 4.85 | 14200.0 | 1 |
| L-lactate dehydrogenase A chain CHEMBL4835 | Ki | 4.85 | 4.85 | 14000.0 | 1 |
| G-protein coupled receptor 55 CHEMBL1075322 | IC50 | 4.85 | 4.85 | 14200.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 4.38 | 4.38 | 42000.0 | 1 |
| Fatty-acid amide hydrolase 1 CHEMBL2243 | IC50 | 4.36 | 4.36 | 43600.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.35 | 4.35 | 45000.0 | 1 |
| Monoacylglycerol lipase ABHD6 CHEMBL2189127 | IC50 | 4.32 | 4.32 | 48200.0 | 1 |
| SH-SY5Y CHEMBL614910 | IC50 | 4.3 | 4.3 | 50000.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.24 | 4.24 | 57000.0 | 1 |
| HepG2 CHEMBL395 | IC50 | 4.23 | 4.23 | 59000.0 | 1 |
| OVCAR CHEMBL614212 | IC50 | 4.2 | 4.2 | 63000.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 4.19 | 4.19 | 65000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 3.2 | mL.min-1.kg-1 | Homo sapiens |
| F | 20.0 | % | Homo sapiens |
| F | 15.0 | % | Homo sapiens |
| Fu | 0.03 | - | - |
| Fu | 0.001 | - | - |
| Fu | 0.03 | - | Homo sapiens |
| Fu | 0.05 | - | Homo sapiens |
| MRT | 46.0 | hr | Homo sapiens |
| t1/2 | - | - | Rattus norvegicus |
| T1/2 | 33.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine